Literature DB >> 15058384

Mapping of a novel MEN-like syndrome locus to rat chromosome 4.

Kamilla Piotrowska1, Natalia S Pellegata, Michael Rosemann, Andreas Fritz, Jochen Graw, Michael J Atkinson.   

Abstract

Multiple endocrine neoplasia-like syndrome (MENX) is a hereditary cancer syndrome in the rat characterized by inborn cataract and multiple tumors affecting the neuroendocrine system developed within the first year of life. The spectrum of affected organs is intermediate between MEN type 1 (MEN1) and MEN type 2 (MEN2) syndromes in human, but, in contrast to them, MENX is inherited in a recessive fashion. Here we report the mapping of the MENX locus to rat Chromosome (Chr) 4 by a genome-wide linkage analysis. This analysis was done in 41 animals obtained from a (Wistar/Nhg x SDwe) x SDwe interstrain backcross, where SDwe (Sprague-Dawley white eye) indicates the affected animals. The MENX disease locus was ultimately mapped to a approximately 22-cM interval on Chr 4 that includes the rat homolog of the human RET proto-oncogene. As activating point mutations of RET are known to be responsible for MEN2 in human, we analyzed several markers located in the proximity of Ret for linkage to the disease phenotype. Our data exclude Ret involvement in MENX and establish that a second gene, playing a role in endocrine tumor formation, lies within the distal part of rat Chr 4. Although heritable human endocrine tumors are quite rare, sporadic tumors of MEN-affected tissues occur at a much higher frequency, and their pathogenesis is poorly understood. The identification of the MENX gene should contribute to our understanding of the genetic mechanisms of neuroendocrine tissue tumorigenesis and may assist in developing new and more appropriate therapeutic strategies for these diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15058384     DOI: 10.1007/s00335-003-3027-8

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  27 in total

1.  Map Manager QTX, cross-platform software for genetic mapping.

Authors:  K F Manly; R H Cudmore; J M Meer
Journal:  Mamm Genome       Date:  2001-12       Impact factor: 2.957

2.  GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

Authors:  C A Landis; S B Masters; A Spada; A M Pace; H R Bourne; L Vallar
Journal:  Nature       Date:  1989-08-31       Impact factor: 49.962

3.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

Authors:  J S Crabtree; P C Scacheri; J M Ward; L Garrett-Beal; M R Emmert-Buck; K A Edgemon; D Lorang; S K Libutti; S C Chandrasekharappa; S J Marx; A M Spiegel; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

4.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

5.  Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.

Authors:  E R Woodward; C Eng; R McMahon; R Voutilainen; N A Affara; B A Ponder; E R Maher
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

Review 6.  Molecular pathogenesis of pituitary tumors.

Authors:  W E Farrell; R N Clayton
Journal:  Front Neuroendocrinol       Date:  2000-07       Impact factor: 8.606

7.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

8.  cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily.

Authors:  T Iwamoto; M Taniguchi; N Asai; K Ohkusu; I Nakashima; M Takahashi
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

Review 9.  The pressure rises: update on the genetics of phaeochromocytoma.

Authors:  Eamonn R Maher; Charis Eng
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

10.  Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.

Authors:  P A Crossey; C Eng; M Ginalska-Malinowska; T W Lennard; D C Wheeler; B A Ponder; E R Maher
Journal:  J Med Genet       Date:  1995-11       Impact factor: 6.318

View more
  4 in total

Review 1.  MEN4 and CDKN1B mutations: the latest of the MEN syndromes.

Authors:  Rami Alrezk; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2017-08-19       Impact factor: 5.678

2.  A patient with MEN1 typical features and MEN2-like features.

Authors:  Diala El-Maouche; James Welch; Sunita K Agarwal; Lee S Weinstein; William F Simonds; Stephen J Marx
Journal:  Int J Endocr Oncol       Date:  2016-04-08

3.  Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.

Authors:  Natalia S Pellegata; Leticia Quintanilla-Martinez; Heide Siggelkow; Elenore Samson; Karin Bink; Heinz Höfler; Falko Fend; Jochen Graw; Michael J Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

4.  Human pheochromocytomas show reduced p27Kip1 expression that is not associated with somatic gene mutations and rarely with deletions.

Authors:  Natalia S Pellegata; Leticia Quintanilla-Martinez; Gisela Keller; Sandya Liyanarachchi; Heinz Höfler; Michael J Atkinson; Falko Fend
Journal:  Virchows Arch       Date:  2007-06-07       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.